Friday, February 11, 2022

Ucello Therapeutics Gets $25M

San Diego- and Chengdu, China-based Ucello Therapeutics, a biotechnology startup which says it is developing universal CAR-T therapies, has raised $25M in a Series A financing round. The company said the funding was led by Matrix Partners China, plus Co-Win Ventures, Northern Light Venture Capital, and Elikon Venture, along with prior investor Chengdu Bio-town Fund. The company is led by Dr

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.